Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

ClinicalTrials.gov ID: NCT07422480

Public ClinicalTrials.gov record NCT07422480. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 3:29 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Open-Label, Randomized Trial to Compare the Efficacy and Safety of Elritercept Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes in ESA-naïve Adult Participants Who Require Red Blood Cell Transfusions

Study identification

NCT ID
NCT07422480
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Takeda
Industry
Enrollment
300 participants

Conditions and interventions

Interventions

  • Elritercept Drug
  • Epoetin Alfa Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 20, 2026
Primary completion
Apr 29, 2029
Completion
Sep 30, 2033
Last update posted
Jun 14, 2026

2026 – 2033

United States locations

U.S. sites
24
U.S. states
16
U.S. cities
23
Facility City State ZIP Site status
Banner MD Anderson Cancer Center Gilbert Arizona 85234 Not yet recruiting
City of Hope - Comprehensive Cancer Center (CCC) Duarte California 91010 Not yet recruiting
Providence Medical Group Santa Rosa California 95403 Not yet recruiting
Cancer & Blood Research Center Whittier California 90720 Not yet recruiting
University of Miami Miami Florida 33136 Not yet recruiting
BRCR Medical Center Inc Tamarac Florida 33321 Recruiting
Emory University Atlanta Georgia 30322 Recruiting
Orchard Healthcare Research Inc. (OHR) - Skokie Skokie Illinois 60077 Recruiting
Norton Cancer Institute Louisville Kentucky 40207 Not yet recruiting
American Oncology Partners P.A. MidAmerica Cancer Care Kansas City Missouri 64132 Recruiting
Albert Einstein College - Montefiore The Bronx New York 10467 Not yet recruiting
Novant Health Care Institute Winston-Salem North Carolina 27106 Not yet recruiting
Cleveland clinic OH Cleveland Ohio 44195 Not yet recruiting
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 Not yet recruiting
Tennessee Oncology, PLLC Nashville Tennessee 37203 Recruiting
World Research Link Baytown Texas 77521 Recruiting
Texas Oncology - Denton Denton Texas 76201 Not yet recruiting
The Center for Cancer and Blood Disorders Fort Worth Texas 76104 Not yet recruiting
The University of Texas-MD Anderson Cancer Center - Leukemia Center Houston Texas 77030 Not yet recruiting
LUMI Research Houston Texas 77090 Not yet recruiting
Renovatio Clinical The Woodlands Texas 77380 Not yet recruiting
Huntsman Cancer Institute Salt Lake City Utah 84124 Not yet recruiting
Virginia Commonwealth University (VCU)-Medical Center - North Hospital Richmond Virginia 23298 Not yet recruiting
West Virginia University Cancer Institute Wheeling West Virginia 26003 Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 130 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07422480, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 14, 2026 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07422480 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →